Table 3.
Factors related to the disease free interval in Wegener's granulomatosis patients.
| Variable | HR | 95%Cl | P |
|---|---|---|---|
| Co-trimoxazole | 0.4 | 0.12-0.69 | 0.003 |
| Presence of PR3-ANCA at the start of study | 2.56 | 1.41-6.35 | 0.004 |
| Chronic nasal carriage of Stapylococcus aureus MRSA | 6.15 | 2.15-33.2 | 0.002 |
| Chronic nasal carriage of Stapylococcus aureus MSSA | 4.56 | 2.45-7.65 | 0.001 |
| Nasal chronic crusting | 3.45 | 1.56-16.7 | 0.0001 |
| Upper respiratory tract infection | 3.72 | 1.65-8.38 | 0.0015 |
| Relapses in anamnesis | 1.07 | 0.89-1.217 | 0.01 |
| GFR ≤ 60 ml/min | 1.67 | 1.37-1.6.35 | 0.02 |